Rheumatoid Arthritis News

The incidence and severity of COVID-19 among patients with rheumatic disease treated with targeted synthetic or biological DMARDs is consistent with those in the general population, according to data published in Arthritis & Rheumatology.

The FDA has approved the sixth biosimilar to adalimumab, adalimumab-fkjp, for all eligible indications of the biologic product, according to a company press release.

Nearly a quarter of strong opioid use among patients with rheumatoid arthritis is potentially attributable to obesity and its associated comorbidities, according to data published in Arthritis Care & Research.

A U.S. appeals court has ruled in favor of two patents for Amgen’s etanercept against the biosimilar etanercept-szzs from Novartis’ Sandoz, upholding a prior decision validating claims of patent infringement.

The sequence of drug tapering — DMARD followed by the TNF inhibitor, or the TNF inhibitor followed by the DMARD — does not impact flare rate or disease activity in patients with rheumatoid arthritis, according to data in Annals of the Rheumatic Diseases.

Among patients with coronary artery disease, rheumatoid arthritis was significantly associated with an elevated risk for myocardial infarction, major adverse cardiovascular events and all-cause mortality, according to data.

The use of TNF inhibitors among patients with autoimmune disease may be associated with an increased risk for inflammatory central nervous system events, according to data published in JAMA Neurology.

Women aged 18 to 45 years with rheumatic diseases want rheumatologists to play an active role in their sexual and reproductive health, according to findings from a series of interviews published in Arthritis Care & Research.

Short interruptions in baricitinib treatment are associated with minor increases in rheumatoid arthritis symptoms, which resolved after recontinuation, according to data published in Arthritis Research & Therapy.

Patients with rheumatic diseases plus COVID-19 are more likely to require mechanical ventilation, but demonstrated similar clinical features and hospitalization rates as those with COVID-19 only, according to data published in the Annals of the Rheumatic Diseases.